FT News Briefing
Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
Fri, 23 Oct 2020
Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.Donald Trump and Joe Biden clash over coronavirus in final debatehttps://www.ft.com/content/bef48683-9bde-4ac2-8906-797779593b22Gilead secures FDA approval for remdesivir https://www.ft.com/content/07a321de-109b-46aa-99bc-f884e0ed7703 Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster